PALO ALTO, Calif., June 14 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX - News) announced today that, in accordance with Nasdaq marketplace rule 4350, the Company issued new inducement stock options to 16 non-executive employees due to additional hiring, primarily in connection with its commercialization efforts in the United States.
